Cohort of IPF Patients Experiencing an Exacerbation

Recruiting now

Conditions studied: Idiopathic Pulmonary Fibrosis

In brief

Extension of the PFBIO cohort which includes patients with newly diagnosed idiopathic pulmonary fibrosis (IPF) for longitudinal follow-up for up to 5 years. In the PFBIO-EXA extension, patients are included if they experience an exacerbation, or other increase in respiratory symptoms requiring hospital admission, for further collection of clinical and biological data.

Key facts

Study ID

NCT04442711

Run by

University Hospital, Gentofte, Copenhagen

People needed

50

Starts

2020-06-13

Expected to finish

2028-12-31

Last updated by the study team

2023-12-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Admitted with an increase in respiratory symptoms
• Already included in PFBIO or included simultaneously in PFBIO and PFBIO-EXA
• Age at least 18 years

You may not qualify if…

• Unable to provide informed consent

Where it is running

• Herlev and Gentofte Hospital — Hellerup, Copenhagen, Denmark (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.